NEW YORK (
) hit a new 52-week high Friday as it is currently trading at $20.33, above its previous 52-week high of $20.30 with 87,298 shares traded as of 10:51 a.m. ET. Average volume has been 1.5 million shares over the past 30 days.
Biomed has a market cap of $2.6 billion and is part of the
industry. Shares are up 7.9% year to date as of the close of trading on Thursday.
BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT) that focuses on providing real estate to the life science industry in the United States. The company has a P/E ratio of 104.7, equal to the average real estate industry P/E ratio and above the S&P 500 P/E ratio of 17.7.
- Practice your BMR trading strategies and win cash in our stock game.
TheStreet Ratings rates Biomed as a
. The company's strengths can be seen in multiple areas, such as its revenue growth, largely solid financial position with reasonable debt levels by most measures and good cash flow from operations. However, as a counter to these strengths, we also find weaknesses including disappointing return on equity, poor profit margins and feeble growth in the company's earnings per share. You can view the full
52-week high stocks
or get investment ideas from our